Filing Details
iBio, Inc. (NASDAQ:IBIO) filed a Form 8-K with the Securities and Exchange Commission on July 01, 2026, disclosing a material event.
8k filedNASDAQ:IBIO
iBio, Inc. (IBIO) Reports Material Event to SEC
Filing Details iBio, Inc. (NASDAQ:IBIO) filed a Form 8-K with the Securities and Exchange Commission on July 01, 2026, disclosing a material event. Market Context iBio, Inc.'s…
Market Context
iBio, Inc.'s stock currently trades at $1.75 with a market capitalization of $39.7M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for iBio, Inc.'s stock.
All SEC filings for iBio, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View IBIO Stock Page
Frequently Asked Questions
Where can I read IBIO's SEC filings?
Browse all filings on our IBIO SEC filings page.
What types of SEC filings does iBio, Inc. file?
Public companies like iBio, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.